Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis

Cells(2024)10.3390/cells13040295Source: DataRank Database

Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis is a research paper published in Cells (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.74)OA: goldTopics (51)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Sathisha Upparahalli Venkateshaiah ORCID,Alok Kumar Verma ORCID,Chandrasekhar Kathera ORCID,Pearce S. Duncan,Michael F. Vaezi ORCID

Live enrichment

PubMed:38391908 OpenAlex:https://openalex.org/W4391574309

NIH

Grant: R01 AI080581

National Institutes of Health

Grant: 2R01AI080581-09A1

Immune signaling molecules involved in promoting the pathogenesis of eosinophilic esophagitis (EoE)

FWCI

1.74

Citation Percentile

0.8%

Citation Trend

2024

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/13/4/295/pdf?version=1707204566

publisherhttps://www.mdpi.com/2073-4409/13/4/295/pdf?version=1707204566

publisherhttps://www.mdpi.com/2073-4409/13/4/295/pdf

journalhttps://doi.org/10.3390/cells13040295

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38391908

Fields of Study

Eosinophilic EsophagitisGastroesophageal reflux and treatmentsFood Allergy and Anaphylaxis Research0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsEnteritisEosinophiliaEosinophilsGastritisHumansMast CellsVasoactive Intestinal PeptideReceptors, Vasoactive Intestinal PeptideInterleukin-13MiceEosinophilic Esophagitis

Keywords

Eosinophilic esophagitisEosinophilMotilityMast cellReceptorMedicinePathologyVasoactive intestinal peptideReceptor antagonistImmunologyAntagonistBiologyInternal medicineCell biologyAsthmaNeuropeptideDiseaseesophagusCRTH2Interleukin-13QH573-671mast cellsArticleEnteritisEosinophilsMiceGastritisEoEEosinophiliaHumansAnimalsReceptors, Vasoactive Intestinal PeptideCytology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being